These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2473238)

  • 1. [Inhibitory effect of sodium pentosan polysulfate on the formation, growth and aggregation of calcium oxalate in vitro].
    Suzuki K; Miyazawa K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):526-31. PubMed ID: 2473238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of sodium pentosan polysulphate (SPP) therapy on the urinary stone disease. Experimental studies on the calcium oxalate crystallization and the effects in healthy subjects].
    Fukatani T
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):246-53. PubMed ID: 1710303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth.
    Martin X; Werness PG; Bergert JH; Smith LH
    J Urol; 1984 Oct; 132(4):786-8. PubMed ID: 6206244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of glycosaminoglycans induced in newly formed calcium oxalate crystals using an undiluted urine system.
    Suzuki K; Tsugawa R
    Scanning Microsc; 1995; 9(4):1089-95; discussion 1095-6. PubMed ID: 8819890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of crystallization on urolithiasis in vitro].
    Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The quantitative study of inhibitory effect of pentosan polysulfate and chlorophyllin on the experimental calcium oxalate stone].
    Miyazawa K; Suzuki K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):861-9. PubMed ID: 2477580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The inhibitory effects of Takusha on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Kawamura K; Moriyama M; Nakajima C; Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1993 Aug; 39(8):695-700. PubMed ID: 8379469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers.
    Norman RW; Scurr DS; Robertson WG; Peacock M
    Br J Urol; 1984 Dec; 56(6):594-8. PubMed ID: 6085478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.
    Senthil D; Subha K; Saravanan N; Varalakshmi P
    Mol Cell Biochem; 1996 Mar; 156(1):31-5. PubMed ID: 8709973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats.
    Nakatani T; Ishii K; Yoneda Y; Kamikawa S; Kanazawa T; Sugimoto T; Osswald H
    Urol Res; 2002 Oct; 30(5):329-35. PubMed ID: 12389123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis.
    Grover PK; Kim DS; Ryall RL
    Mol Med; 2002 Apr; 8(4):200-9. PubMed ID: 12149569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of factors affecting calcium oxalate crystalline aggregation.
    Grases F; Costa-Bauzá A
    Br J Urol; 1990 Sep; 66(3):240-4. PubMed ID: 1698500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of preincubation of seed crystals of uric acid and monosodium urate with undiluted human urine to induce precipitation of calcium oxalate in vitro : implications for urinary stone formation.
    Grover PK; Ryall RL
    Mol Med; 2002 Sep; 8(9):525-35. PubMed ID: 12456991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium pentosan polysulphate as a polyanionic inhibitor of calcium oxalate crystallization in vitro and in vivo.
    Norman RW; Scurr DS; Robertson WG; Peacock M
    Clin Sci (Lond); 1985 Mar; 68(3):369-71. PubMed ID: 2578913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The development of continuous crystallizer and observation of formation and growth of calcium oxalate crystals].
    Suzuki K; Domiki C; Tsugawa R
    Hinyokika Kiyo; 1991 Jun; 37(6):569-75. PubMed ID: 1716408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium pentosan polysulphate--a novel inhibitor of urinary risk factors and enzymes in experimental urolithiatic rats.
    Senthil D; Malini MM; Varalakshmi P
    Ren Fail; 1998 Jul; 20(4):573-80. PubMed ID: 9713875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of osteopontin on calcium oxalate crystal formation.
    Konya E; Umekawa T; Iguchi M; Kurita T
    Eur Urol; 2003 May; 43(5):564-71. PubMed ID: 12706004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of kanpou medicine on the growth and aggregation of calcium oxalate crystals in vitro].
    Utsunomiya M; Koide T; Yamaguchi S; Yoshioka T; Sonoda T; Sugiyama K
    Hinyokika Kiyo; 1991 Oct; 37(10):1097-101. PubMed ID: 1755397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.